ArticleOncotarget2017

Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer.

Qian-Qian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.